OPAL token launch of EZZ products sells $100k in first week
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Xenitra Limited has announced the successful launch of its OPAL tokenised sales ecosystem, reporting significant sales in the first week of EZZ products. This launch is part of a broader strategy to integrate tokenisation into their sales model, enhancing customer engagement and loyalty. The announcement highlights the potential for scaling this model across various brands and markets in the future.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Xenitra
- Q3 Sales rise by over 305% to $8.3m
- Acquisition of Fukang OTC Pharmacy
- OPAL Token & Xen Shop Launch - Next-Gen Digital Commerce
- $30m Danone - Rockcheck Strategic Partnership
- Half Yearly Report and Accounts
Later from Xenitra
- $1.25m Raised to Support Next Phase of Growth
- Product sales of $500k in first month of OPAL token launch
- XEN Appointed as Exclusive Biomiq Skincare China Distributor
- $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks
- $12M offtake agreement with leading OTC-pharmaceutical
Follow Xenitra into a list and get an email when it puts out news.
Follow Xenitra